Need advice? Keen to get the best deal? Call now on +44 (0)1494
This report will allow you to:
Profit from 40 new executive interviews with market leading companies.
Learn about key home health monitoring devices and services. Study the strategies of 124 key players in the mHealth ecosystem.
Understand the dynamics of the health monitoring market in Europe and
Comprehend how wireless technology can become seamlessly integrated with medical devices. Evaluate the business opportunities in the emerging mHealth segment.
Predict future market and technology developments.
This report answers the following questions:
Which medical conditions offer the best potential for wireless
health monitoring solutions?
Who are the leading providers of connected medical devices?
What are the mHealth strategies of medical device vendors and pharmaceutical companies?
Which are the general technology trends for home health monitoring equipment?
What initiatives have been taken by the leading players in the telecom and IT industries?
How can connectivity redefine the use cases of medical devices and the value propositions to patients and other
What are the market shares of the top 5 integrated telehealth solution vendors?
Why are smartphone applications so significant for the mHealth market?
How can healthcare providers and payers benefit from mHealth solutions?
7.1 million patients worldwide are remotely monitored
The number of remotely monitored patients grew by 44 percent to 7.1
million in 2016 as the market entered a growth phase fuelled by rising
market acceptance in several key verticals. This number includes all
patients enrolled in mHealth care programs in which connected medical
devices are used as a part of the care regimen. Connected medical
devices used for various forms of personal health tracking are not
included in this figure. Berg Insight estimates that the number of remotely
monitored patients will grow at a compound annual growth rate (CAGR)
of 47.9 percent to reach 50.2 million by 2021. Cellular connectivity
has already replaced PSTN as the de-facto standard communication
technology for most types of connected home medical monitoring devices
and will account for 25.2 million connections in 2021. Using patients’ own
mobile devices as health hubs is now becoming a viable alternative for
remote patient monitoring. BYOD connectivity will be preferred by select
patient groups and will be used for the remote monitoring of 22.9 million
patients in 2021.
Berg Insight estimates that revenues for remote patient monitoring
(RPM) solutions reached € 7.5 billion in 2016, including revenues from
medical monitoring devices, mHealth connectivity solutions, care delivery
platforms and mHealth care programs. RPM revenues are expected
to grow at a CAGR of 33.8 percent between 2016 and 2021 to reach
€ 32.4 billion at the end of the forecast period. Connected medical devices
accounted for 67.5 percent of total RPM revenues in 2016. However,
revenues for mHealth connectivity solutions, care delivery platforms and
mHealth care programs are growing at a faster rate and will account for
51.3 percent of total revenues in 2021, up from just 32.5 percent in 2016.
There is a strong trend towards incorporating more connectivity in
medical devices and pharmaceuticals in order to enable new services
and value propositions. Implantable cardiac rhythm management (CRM)
has traditionally been the largest market segment, led by companies such
as Medtronic, Biotronik and St Jude Medical (now Abbott) that included
connectivity in CRM solutions more than a decade ago. However, the
sleep therapy segment is growing at the fastest rate and surpassed CRM
in 2016. The number of remotely monitored sleep therapy patients grew
by 70 percent in 2016, with market growth mainly driven by the vendor
ResMed that has made connected healthcare a cornerstone of its strategy.
Berg Insight predicts that three of the fastest growing market segments
in the next five years will be glucose monitoring, air flow monitoring and
connected pharmaceuticals. Today, the leading connected healthcare
players in these segments include forward-thinking incumbents as well
as innovative new entrants such as AstraZeneca, Dexcom, Merck
Group, Novartis, Propeller Health, Proteus Digital Health, Roche, Sanofi,
Voluntis and WellDoc.
Care delivery platforms and mHealth connectivity solutions are two of
the most rapidly developing parts of the mHealth technology value chain.
Care delivery platforms are software solutions that enable the remote
delivery of healthcare services and allow care efforts to be coordinated
between patients, various professional caregivers and other stakeholders
such as the patient’s family. Care delivery platforms will be instrumental
for engaging patients in their own care and delivering remote monitoring
services to a large number of people in a cost efficient way. There are
various types of care delivery platforms available on the market. Generalpurpose
platforms can be adapted to a wide variety of use cases and
are often used as the foundation for developing therapeutic area specific
mHealth products. Companies that specialize in this area include
BePatient, Exco InTouch, Medixine, OpenTeleHealth and Vivify Health.
mHealth connectivity solutions include products and services that are
used for collecting data from medical monitoring devices, transmitting
this data to caregivers and enabling the data to be used by care delivery
platforms. The leading players include Qualcomm Life, eDevice/iHealth,
Tactio Health, Validic and MedM.
Health-related apps and devices are generating potentially huge amounts
of data. When the line between medical devices and health gadgets
become blurred, traditional as well as startup companies try to position
themselves as important stakeholders in the ecosystem for mHealth data.
National PHR systems, device manufacturing companies, independent
app producers and tech giants such as Google, Apple, Microsoft are
some common options for data storage. One trend is to share data in
third party clouds, exemplified by Glooko that allows people suffering
from diabetes to download their glucose readings to their mobile devices,
regardless of the brand of the glucose reading device. Important for endusers,
doctors and care giving institutions is to choose a place where
as many standards as possible are followed and where it is as easy as
possible to export the data.